Polycystic Ovary Syndrome is well known to cause various metabolic changes in the body; however, changes in the ocular surface are not fully understood or well-described in the existing literature. Hormonal disturbances resulting from PCOS may affect multiple ocular tissues, including the posterior segment, lacrimal and meibomian glands, cornea, and conjunctiva.
Objective
This paper aims to summarize the current knowledge and research regarding ocular alterations related to PCOS.
Method
A comprehensive review of the existing literature was conducted by searching multiple databases, including Scopus, PubMed, and Google Scholar. Keywords such as “Polycystic Ovary Syndrome,” “PCOS,” “ocular surface,” “dry eye,” “meibomian gland dysfunction,” and “ocular changes” were used. Relevant case reports and clinical studies were included to provide a comprehensive understanding of the ocular implications of PCOS.
Results
Among the ocular changes associated with PCOS, dry eyes are the most common source of irritation and discomfort in affected individuals. Recognizing this association is crucial for eye care practitioners.
Conclusion
Identifying the link between PCOS and dry eyes enables practitioners to develop personalized management plans for individuals with PCOS, potentially improving their eye health and comfort in longer run. When necessary, further evaluation or referral may be required for patients with PCOS-related ocular symptoms.
SteinIFLeventhalML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol1935; 29: 181–191.
2.
DeansR. Polycystic ovary syndrome in adolescence. Med Sci (Basel)2019; 7: 101.
3.
WitchelSFOberfieldSEPeñaAS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc2019; 3: 1545–1573.
4.
SadeghiHMAdeliICalinaD, et al.Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci2022; 23: 583.
5.
KhomamiMBTehraniFRHashemiS, et al.Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS One2015; 10: e0123608.
6.
MarchWAMooreVMWillsonKJ, et al.The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod2010; 25: 544–551.
7.
LiYLiYNgEH, et al.Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril2011; 96: 452–458.
8.
BharathiRVSwethaSNeerajaaJ, et al.An epidemiological survey: effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J2017; 22: 313–316.
9.
YiiMFLimCELuoX, et al.Polycystic ovarian syndrome in adolescence. Gynecol Endocrinol2009; 25: 634–639.
10.
MicucciCValliDMatacchioneG, et al.Current perspectives between metabolic syndrome and cancer. Oncotarget2016; 7: 38959.
11.
KumarapeliVLSeneviratneRDWijeyaratneCN. Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in south Asian women. BJOG: Int J Obstet Gynaecol2011; 118: 319–328.
12.
BaserGYildizNCalanM. Evaluation of meibomian gland dysfunction in polycystic ovary syndrome and obesity. Curr Eye Res2017; 42: 661–665.
13.
YücekulBGürlekB. Non-invasive evaluation of meibomian gland morphology and tear film and anterior segment parameters in women with polycystic ovarian syndrome. Photodiagn Photodyn Ther2022; 37: 102654.
14.
WolfWMWattickRAKinkadeON, et al.Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health2018; 15: 2589.
15.
MantelliFMorettiCMacchiI, et al.Effects of sex hormones on ocular surface epithelia: lessons learned from polycystic ovary syndrome. J Cell Physiol2016; 231: 971–975.
16.
WickhamLAGaoJTodaI, et al.Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand2000; 78: 146–153.
17.
SullivanDASullivanBDUllmanMD, et al.Androgen influence on the meibomian gland. Invest Ophthalmol Visual Sci2000; 41: 3732–3742.
18.
TruongSColeNStapletonF, et al.Sex hormones and the dry eye. Clin Exp Optom2014; 97: 324–336.
19.
PontelliRCSouzaMCFantucciMZ, et al.The role of endocrine disruptors in ocular surface diseases. Med Hypotheses2019; 122: 157–164.
20.
OzdemirMTemizdemirH. Age-and gender-related tear function changes in normal population. Eye2010; 24: 79–83.
21.
BoniniSMantelliFMorettiC, et al.Itchy-dry eye associated with polycystic ovary syndrome. Am J Ophthalmol2007; 143: 763–771.
22.
TsubotaKPflugfelderSCLiuZ, et al.Defining dry eye from a clinical perspective. Int J Mol Sci2020; 21: 9271.
23.
PultHPurslowCMurphyPJ. The relationship between clinical signs and dry eye symptoms. Eye2011; 25: 502–510.
24.
BronAJTiffanyJMGouveiaSM, et al.Functional aspects of the tear film lipid layer. Exp Eye Res2004; 78: 347–360.
GeorgievGAEftimovPYokoiN. Contribution of mucins towards the physical properties of the tear film: a modern update. Int J Mol Sci2019; 20: 6132.
27.
VehofJHysiPGHammondCJ. A metabolome-wide study of dry eye disease reveals serum androgens as biomarkers. Ophthalmology2017; 124: 505–511.
28.
SchaumbergDABuringJESullivanDA, et al.Hormone replacement therapy and dry eye syndrome. Jama2001; 286: 2114–2119.
29.
HartRHickeyMFranksS. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol2004; 18: 671–683.
30.
AritaRItohKMaedaS, et al.Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye. Jpn J Ophthalmol2010; 54: 387–391.
KnopEKnopNMillarT, et al.The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Visual Sci2011; 52: 1938–1978.
33.
RolandoMMerayo-LlovesJ. Management strategies for evaporative dry eye disease and future perspective. Curr Eye Res2022; 47: 813–823.
34.
KrenzerKLReza DanaMUllmanMD, et al.Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab2000; 85: 4874–4882.
35.
WangLXDengYP. Androgen and meibomian gland dysfunction: from basic molecular biology to clinical applications. Int J Ophthalmol2021; 14: 915.
36.
SullivanBDEvansJEDanaMR, et al.Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol2006; 124: 1286–1292.
37.
ZouboulisCCChenWCThorntonMJ, et al.Sexual hormones in human skin. Horm Metab Res2007; 39: 85–95.
38.
OrioFPalombaS. New guidelines for the diagnosis and treatment of PCOS. Nat Rev Endocrinol2014; 10: 130–132.
39.
RescherLSinghSZahnI, et al.Effect of metformin on meibomian gland epithelial cells: implications in aging and diabetic dry eye disease. Life2024; 14: 1682.
40.
HeBIovienoAEtminanM, et al.Effects of hormonal contraceptives on dry eye disease: a population-based study. Eye2022; 36: 634–638.
41.
GonenTCelikCOznurM, et al.Tear osmolarity and ocular surface changes in patient with polycystic ovary syndrome. Curr Eye Res2013; 38: 621–625.
42.
BaudouinC. The pathology of dry eye. Surv Ophthalmol2001; 45: S211–S220.
43.
GuptaPDJoharKSrNagpalK, et al.Sex hormone receptors in the human eye. Surv Ophthalmol2005; 50: 274–284.
44.
AlbietzJM. Dry eye: an update on clinical diagnosis, management and promising new treatments. Clin Exp Optom2001; 84: 4–18.
45.
GipsonIKArguesoP. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol2003; 231: 1–49.
46.
MantelliFMorettiCMiceraA, et al.Conjunctival mucin deficiency in complete androgen insensitivity syndrome (CAIS). Graefe's Arch Clin Exp Ophthalmol2007; 245: 899–902.
47.
BerryMPultHPurslowC, et al.Mucins and ocular signs in symptomatic and asymptomatic contact lens wear. Optom Vis Sci2008; 85: E930–E938.
48.
BoniniSLeonardiA. The multifaceted aspects of ocular allergies: phenotypes and endotypes. Ocul Surf2022; 26: 174–183.
49.
SacchettiMLambiaseAMorettiC, et al.Sex hormones in allergic conjunctivitis: altered levels of circulating androgens and estrogens in children and adolescents with vernal keratoconjunctivitis. J Immunol Res2015; 2015: 945317.
50.
NaritaSIGoldblumRMWatsonCS, et al.Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect2007; 115: 48–52.
51.
LvWSongYFuR, et al.Deep learning algorithm for automated detection of polycystic ovary syndrome using scleral images. Front Endocrinol (Lausanne)2022; 12: 789878.
52.
GiuffrèGDi RosaLFiorinoF, et al.Variations in central corneal thickness during the menstrual cycle in women. Cornea2007; 26: 144–146.
53.
LeachNEWallisNELothringerLL, et al.Corneal hydration changes during the normal menstrual cycle–a preliminary study. J Reprod Med1971; 6: 201–204.
54.
OliverKMWalshGTomlinsonA, et al.Effect of the menstrual cycle on corneal curvature. Ophthalmic Physiol Opt1996; 16: 467–473.
55.
SuzukiTKinoshitaYTachibanaM, et al.Expression of sex steroid hormone receptors in human cornea. Curr Eye Res2001; 22: 28–33.
56.
KebapcilarAGTatarMGIpekciSH, et al.Cornea in PCOS patients as a possible target of IGF-1 action and insulin resistance. Arch Gynecol Obstet2014; 290: 1255–1263.
57.
Cengiz OzturkTGAkcamHTEllibes KayaA. Pentacam corneal topography and densitometry features of PCOS patients. BMC Ophthalmol2023; 23: 5.
58.
OguetaSBSchwartzSDYamashitaCK, et al.Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Visual Sci1999; 40: 1906–1911.
59.
Souza-JúniorJEGarciaCASoaresEM, et al.Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography. J Ophthalmol2015; 2015: 193078.
60.
DemirMGuvenDKocA, et al.Retinal nerve fiber layer thickness in women with polycystic ovary syndrome. J Ophthalmol2013; 2013: 752186.
61.
OvalleFAzzizR. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril2002; 77: 1095–1105.
62.
FongDSAielloLPFerrisFLIII, et al.Diabetic retinopathy. Diabetes Care2004; 27: 2540–2553.
63.
AlpoganODonmezEEVuralF, et al.Effects of androgens on the thickness of retinal layers in transgender men and in women with polycystic ovarian syndrome. Transgender Health2022; 8: 363–370.
64.
AlpoganODonmezEEBalıkAÖ, et al.Effects of testosterone on intraocular pressure, thicknesses of retinal nerve fiber layer, ganglion cell complex, macula and on ocular blood flow in female-to-male transgender persons. Int Ophthalmol2021; 41: 3651–3661.
65.
AlhamzawiZAAbdullaMGAlbughanimAS. The relation between intraocular pressure level and polycystic ovarian disease. Eurasian Med Res Periodical2022; 13: 114–119.
